JULIA DANIEL: Open Payments
NPI 1356574933 · DAHLONEGA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 17 payments from 12 companies in 2025. Trend: 2023 $190 · 2024 $253 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $29 |
| Corium, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Lilly USA, LLC | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Dexcom G6 Transmitter, CAPLYTA, JARDIANCE, Azstarys, TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, The Cologuard Plus Collection Kit.
Industry payments across GA — which companies pay providers there.
